Upstate Active Clinical Trials
Study Title:
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and NeckUpstate Institutional Review Board (IRB) Number:
501348Study/Protocol ID:
RTOG-1216Study Phase:
II/IIIPatient Age Group:
AdultsPrincipal Investigator:
Seung Shin Hahn, MDWhat is involved if I participate?
- Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes
Where will the study take place?
Oneida Medical Oncology and Radiation OncologyOswego Medical Oncology and Radiation Oncology
The Hill Medical Center Radiation Oncology
ClinicalTrials.Gov ID:
NCT01810913For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: Laine Abernathy
Phone: 315-464-6528
Email: abernatl@upstate.edu